Effect of molecular weight of PGG–paclitaxel conjugates on in vitro and in vivo efficacy
Authors:
- 12 April 2012
- journal article
- Published by Elsevier in Journal of Controlled Release
- Vol. 161 (1) , 124-131
Abstract
No abstract availableKeywords
This publication has 31 references indexed in Scilit:
- Nanoparticle therapeutics: an emerging treatment modality for cancerNature Reviews Drug Discovery, 2008
- Recent Trends in Targeted Anticancer Prodrug and Conjugate DesignCurrent Medicinal Chemistry, 2008
- Pluronic block copolymers alter apoptotic signal transduction of doxorubicin in drug-resistant cancer cellsJournal of Controlled Release, 2005
- Effect of Pluronic P85 on ATPase Activity of Drug Efflux TransportersPharmaceutical Research, 2004
- Sensitization of Cells Overexpressing Multidrug-Resistant Proteins by Pluronic P85Pharmaceutical Research, 2003
- Targetable HPMA copolymer-adriamycin conjugates. Recognition, internalization, and subcellular fateJournal of Controlled Release, 1998
- Hypersensitization of Multidrug Resistant Human Ovarian Carcinoma Cells by Pluronic P85 Block CopolymerBioconjugate Chemistry, 1996
- Polymer conjugates with anticancer activity1995
- Prodrugs of Peptides. 11. Chemical and Enzymatic Hydrolysis Kinetics of N-Acyloxymethyl Derivatives of a Peptide-like BondPharmaceutical Research, 1991
- Prodrugs of Peptides. 9. Bioreversible N-α-Hydroxyalkylation of the Peptide Bond to Effect Protection Against Carboxypeptidase or Other Proteolytic EnzymesPharmaceutical Research, 1991